Ciliary neurotrophic factor

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
90	網膜色素変性症	4

90. 網膜色素変性症

臨床試験数 : 147 / 薬物数 : 176 - (DrugBank : 43) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 110

trials per page:

Showing 1 to 4 of 4 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01530659 (ClinicalTrials.gov)	January 2012	19/1/2012	Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retini ...	Photoreceptor Structure in A Phase 2 Study of Encapsulated Human NTC-201 Cell Implants Releasing Cil ...	Retinitis Pigmentosa;Usher Syndrome Type 2;Usher Syndrome Type 3	Drug: NT-501;Procedure: Sham	Neurotech Pharmaceuticals	University of California, San Francisco	Completed	18 Years	55 Years	All	22	Phase 2	United States
2	NCT00447980 (ClinicalTrials.gov)	January 2007	9/3/2007	A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pi ...	A Phase II/III Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Fact ...	Retinitis Pigmentosa	Drug: NT-501	Neurotech Pharmaceuticals	NULL	Completed	18 Years	64 Years	Both	68	Phase 2	United States
3	NCT00447993 (ClinicalTrials.gov)	January 2007	9/3/2007	A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigment ...	A Phase II/III Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Fact ...	Retinitis Pigmentosa	Drug: NT-501	Neurotech Pharmaceuticals	NULL	Completed	18 Years	68 Years	Both	65	Phase 2	United States
4	NCT00063765 (ClinicalTrials.gov)	June 2003	3/7/2003	Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye	A Phase I Study of NT-501-10 and NT-501-6A.02, Implants of Encapsulated Human NTC-210 Cells Releasin ...	Retinitis Pigmentosa	Drug: Ciliary Neurotrophic Factor Implant NT-501	National Eye Institute (NEI)	NULL	Completed	N/A	N/A	Both	10	Phase 1	United States

First Previous1Next Last